HSA-free formulations of interferon-beta

Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (1FN-²) and methods useful in their preparation are provided. The compositions comprise the IFN-² solubilised in a low-ionic-strength formulation that maintains the composition at a pH of about 5.0. Methods for...

Full description

Saved in:
Bibliographic Details
Main Authors SHIRLEY, BRET, BABUKA, SUSAN, TELLERS, MELANIE, CHOE, MINNA
Format Patent
LanguageEnglish
French
German
Published 16.02.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (1FN-²) and methods useful in their preparation are provided. The compositions comprise the IFN-² solubilised in a low-ionic-strength formulation that maintains the composition at a pH of about 5.0. Methods for preparing these compositions, and for increasing solubility of IFN-² in pharmaceutical compositions, are provided.
Bibliography:Application Number: EP20100180630